Several species of ginseng are known to exist: American, Chinese, Korean, Japanese, and Siberian (Barna, 1985) . Three medicinal species of ginseng are currently recognized: Panax ginseng C.A. Meyer (Chinese or Korean ginseng, a perennial herb indigenous to the mountainous forests of Eastern Asia); Panax japonicus C.A. Meyer (Japanese ginseng, from India, Southern China, and Japan); and Panax quinquefolius (American ginseng, found growing in rich woodland in the eastern and central U.S. and Canada) (Court, 1975; Popov & Goldwag, 1973; Williams, 1957) .
A preparation of Korean ginseng containing a standardized concentration of ginsenosides has been used in a number of clinical and pharmacological studies. This preparation, known as G115 (G115 is the registered trademark of a ginseng extract containing all ginsenosides from the Korean Panax ginseng, GPL Ginsana Products SA, Lugano, Switzerland) and marketed under the name of Ginsana, is widely used for the treatment of a variety of problems such as reduced performance associated with general fatigue states. Since these preparations sometimes contain other substances (e.g., alcohol, vitamins, minerals) (Pietta, Mauri, & Rava, 1986) , it is difficult to conclude that ginseng per se possesses efficacy.
Siberian or Russian ginseng, although reported to have the same stimulant and tonic effects as the other ginseng products, is an entirely different plant, Eleutherococcus senticosus (Baranov, 1982; Brekman, 1965) . The terms ciwujia, devil's bush, wild pepper, and shigoka are often used as synonyms for Siberian ginseng.
Eleutherococcus senticosus has been used as an inexpensive substitute for the ginseng roots of Panax ginseng C.A. Meyer (Araliaceae) in republics of the former Soviet Union and other countries. In reviewing the medicinal uses of ginseng and related plants in the Soviet Union, Baranov (1982) concluded that: (i) administration of E. senticosus (eleuthero), unlike ginseng, never produces excitation in patients; (ii) the effect of eleuthero on the general immunity of an organism is more universal than that of ginseng; (iii) ginseng has anti-stress effects but, under certain conditions, may produce a stress-like syndrome (eleuthero has no such effect); and (iv) the effect of both ginseng and eleuthero varies seasonally, but this is less so for eleuthero.
Like Siberian or Russian ginseng, Panax japonicus C.A. Meyer has been used in Japan as a substitute for Panax ginseng C.A. Meyer in the treatment of gastroenteric disorder and as an antitussive, expectorant and antipyretic. American ginseng (Panax quiquefolius) is sold worldwide in forms such as processed roots, powders, teas, and capsules. It is used as an analeptic, tonic, stomach pain analgesic, and adaptogenic agent (any substance that exerts effects on both sick and healthy individuals by "correcting" any dysfunction(s) without producing unwanted side effects (Davydov & Krikorian, 2000) ). It has also been widely promoted as an aphrodisiac (Liberti & Der Marderosian, 1978) .
The main active constituents of the Panax species are recognized to be triterpenoid glycosides or saponins and are termed ginsenosides by Chinese, Korean, and Japanese researchers, while the active components of Eleutherococcus senticosus are termed panaxosides by Russian workers, whose structures and distribution vary with species and variety. Identification of the active elements, the establishment of reliable techniques for the isolation and standardization of the active components, and the extensive evaluation of the active components and pharmacological properties has occurred during the past few decades (Hou, 1977; Iwabuchi, Yoshikura, Ikawa, & Kamisako, 1987; Iwabuchi, Yoshikura, & Kamisako, 1988; Kasai, Yamaguchi, & Tanaka, 1987) . Chromatographic methods are now available for the identification of saponins that make ginseng detection and differentiation relatively simple (Liberti & Der Marderosian, 1978; Phillipson & Anderson, 1984; Pietta, Mauri, & Rava, 1986; Shibata, Fujita, Itokawa, Tanaka, & Ishii, 1963; Tanaka, Nagai, & Shibata, 1966; Yamaguchi, Kasai, Matsuura, Tanaka, & Fuwa, 1988) . Ginseng saponins have been investigated (Iida, Tanaka, & Shibata, 1968; Tanaka, Nagai, & Shibata, 1966; Wenkui, Chungang, Zhang, Awang, Fitzloff, Fong, & van Breeman, 2000) , and at least 31 saponins have been isolated from extracts of Panax ginseng roots (Court, 1975; Hou, 1977) . The major saponins have been named ginsenosides Rx, where x is a, b 1 , b 2 , c, d, e, f, g 1 , g 2 , g 3 , h 1 , h 2 , or o, according to their position on thin layer chromatograms (Shibata, Tanaka, Soma, Iida, Ando, & Nakamura, 1965) .
Among the various types of ginseng, Korean ginseng appears to be relatively rich in ginsenosides. In Korean Panax ginseng, ginsenosides Rb 1 , Rc, and Rg 1 are major saponins, and although American P. quinquefolius is similar in its constituents there are significant differences (Besso, Kasai, Wei, Wang, Saruwatari, Fuwa, & Tanaka, 1982; Phillipson & Anderson, 1984) . The most significant difference between American and Korean ginsengs is that American ginseng is believed to have cooling and energizing effects on the body, whereas Korean ginseng is thought to have warming and calming effects on the body. The roots of Japanese ginseng, Panax japonicus, contain mainly different saponins, which are known as chikusetsu-saponins. Only two saponin glycosides are common to Japanese, Chinese, Korean, and American ginseng, namely Rg 2 , and Ro (Russian panaxosides do not correspond with those of the ginsenosides).
The active constituents of Russian ginseng (E. senticosus) are a series of eleutherosides coded A to F (Elyakov, Strigina, Uvarova, Vaskovasky, Dzizenko, & Kochetkov, 1964) . The major eleutherosides are completely different in chemical structure from the ginsenosides. The resultant variety of saponins which can co-occur, each with its own pharmacological activity, is probably responsible for the lack of consensus among researchers on the pharmacology of ginseng. In fact, in the U.S., the 2002 Farm Security & Rural Investment Act (United States Department of Agriculture, 2002) states that "the term 'ginseng' may only be considered to be a common or usual name (or part thereof) for any herb or herbal ingredient derived from a plant classified within the genus Panax and only labeling or advertising for herbs or herbal ingredients classified within that genus may include the term 'ginseng'".
Ginseng grows wild, is also cultivated, and is generally harvested after growing six to seven years. Although the entire ginseng plant contains pharmacologically active properties (Petkov, Yinglin, Todorov, Lazarova, Getova, Stancheva, & Alova, 1992) , it is the root of the plant that is considered most valuable. In fact, over $81,000 has been paid for a small, 124-year-old ginseng root (CNN.com/WORLD, 2001 ). Extracts of red and white ginseng contain different ginsenosides (Chong & Oberholzer, 1988) . White ginseng is produced by air-drying the root, while red ginseng is produced by steaming the root followed by drying. Red ginseng has been used for treatment of weak constitution, ulcers, cold symptoms or anemia, and as an analeptic, a stomachic, and as an erythropoietic within the traditional Chinese system of medicine (Matsuda, Namba, Fukuda, Tani, & Kubo, 1986) . The latter, i.e., erythropoiesis, is potentially relevant for application with athletes engaged in endurance events. The ginsenoside content of dried ginseng root may vary with root age, method of preservation, and season of harvest (Liberti & Der Marderosian, 1978 ). High quality ginseng should be collected in the autumn and never before five to six years of growth (Popov & Goldwag, 1973) . For example, while most roots present at least four detectable ginsenosides, after six years of growth roots show more extensive patterns and may yield up to nine ginsenosides (Liberti & Der Marderosian, 1978) .
Physiological Effects
Previous reviews have documented the physiological effects of ginseng (Bahrke & Morgan, 1994; Bahrke & Morgan, 2000) . Studies dealing with the cardiovascular effects of ginseng, have reported that various preparations and concentrations can reduce, elevate, or stabilize blood pressure, and influence platelet aggregation. It appears that ginsenosides can have hypertensive as well as hypotensive effects. However, these effects are transient, relatively minor, and dose dependent. Research published since our last review also indicates that ginseng may improve cardiovascular and pulmonary function, and this could enhance physical performance.
In a randomized, double-blind, placebo-controlled trial, Stavro, Woo, Heim, Leiter, and Vukan (2005) investigated the effect of six batches of North American ginseng root that varied in quality and ginsenoside content on blood pressure in 16 hypertensive individuals, but not performance in healthy athletes. None of the North American ginsengs or their mean differed from placebo in their effect on overall mean blood pressure change suggesting that North American ginseng has no effect on blood pressure in hypertensive individuals.
The effects of ginseng on pulmonary function and exercise capacity have been reported in earlier studies. However, many of these investigations have been conducted with patients suffering from compromised pulmonary function and low levels of exercise capacity. In an investigation designed to evaluate the effects of ginseng extract (G115) on pulmonary function and exercise capacity, Gross, Shenkman, Bleiberg, Dayan, Gittleson, and Efrat (2002) assigned 94 patients with moderately-severe chronic obstructive pulmonary disease to either an experimental group that received 100 mg of G115, twice daily, or a control group that received a placebo over a 3-month study period. Pulmonary function tests: maximum voluntary ventilation and maximum inspiratory pressure were administered prior to treatment and every two weeks during the 3-month period. Exercise tests and VO 2 max measurements were performed before beginning treatment, at 6 weeks, and after 3 months. In the experimental treatment, but not the placebo treatment, all parameters significantly increased above baseline and surpassed those changes noted for the placebo group. Maximum voluntary ventilation increased 40%, maximum inspiratory pressure improved 47%, and maximal oxygen consumption increased 38%. No side effects were observed. It appears ginseng may have its most significant effects in individuals with compromised respiratory systems, but this cannot be taken to assume it would have an effect on healthy athletes.
Effects on Physical Activity, Stress, and Fatigue
Ginseng and ginseng-related products have been used for years as an energy booster and as a general tonic. Some reports suggest ginseng may enhance antibody production and natural killer cell activity and play a role in the prevention and therapy of respiratory disorders (Choi, 2008) . There is evidence that intense physical training can produce temporary changes in the endocrine and immune systems and one of the reasons athletes use Panax ginseng or Eleutherococcus senticosus is the belief that these herbs decrease the incidence of colds and infections and enhance recovery from intense training.
Stress and Immune System. Gaffney, Hugel, and Rich (2001a) , using a 6-week, doubleblind, placebo-controlled study examined the ability of Panax ginseng (type not specified) and Eleutherococcus senticosus to influence measures of stress and selected parameters of immune system status in competitive club-level, male athletes engaged in normal training during the competitive season. Thirty participants were matched for training stress and received a 33% ethanolic extract containing either a Panax ginseng treatment, an Eleutherococcus senticosus treatment, or a placebo treatment. A pre-test and post-test were used to evaluate the effects of 6 weeks of supplementation on cortisol, testosterone, and testosterone to cortisol ratio as well as circulating numbers of T-cells, T-helper cells (CD4), T-suppressor cells (CD8), CD4 to CD8 ratio, natural killer cells, and B lymphocytes. None of the immune system variables changed significantly nor showed any clear trend from pre-to post test in any of the treatment groups. No significant change in testosterone, cortisol, or total testosterone to cortisol ratio (TCR) was observed in the Panax ginseng treatment group. However, in the Eleutherococcus senticosus treatment group, TCR significantly decreased by 28.7%. The main contribution to this decrease appeared to be a non-significant trend towards increased cortisol rather than a small decrease in mean testosterone levels. These results suggest that Eleutherococcus senticosus increased rather than decreased hormonal indices of stress. There is animal research suggesting a threshold of stress below which Eleutherococcus senticosus increases the stress response and above which Eleutherococcus senticosus decreases the stress response (Gaffney, Hugel, & Rich, 2001a ). Gaffney, Hugel, and Rich (2001b) have proposed a mechanism of action for Panax ginseng and Eleutherococcus senticosus that attempts to explain why these herbs produce the paradoxical effect of sometimes increasing and sometimes decreasing the stress response. The mechanism suggests this biphasic effect results from increased occupancy of positive and negative feedback stress hormone receptors by their natural ligands to inhibition of specific enzymes that function to limit receptor occupancy.
Specifically, Gaffney et al. (2001b) suggest that Panax ginseng inhibits 11-beta hydroxysteroid dehydrogenase one and Eleutherococcus senticosus inhibits catechol-Omethyl transferase, both of which reside in close proximity to stress hormone receptors and catalyze the degradation of stress hormones into inactive compounds. In addition, Gaffney et al. (2001b) suggest the increased energy claimed to result from Panax ginseng and Eleutherococcus senticosus may be a consequence of their increasing the occupancy of stress hormone receptors that function to redistribute the body's energy reserves from regeneration to activity.
In an investigation designed to examine the efficacy of ginseng to modulate secretory immunoglobulin A, exercise performance, and recovery from repeated bouts of strenuous physical exertion, Engels, Fahlman, and Wirth (2003) used a double-blind, placebo-controlled, randomized design with 38 active healthy adults who supplemented their diets with a standardized ginseng concentrate (400 mg G115) or placebo for 8 weeks. Prior to and following the treatments, each subject performed 3 consecutive 30-second Wingate tests interspersed with 3-minute recovery periods. Secretory immunoglobulin A secretion rate (S-SIgA) and the relation of secretory immunoglobulin A (SIgA) to total protein were calculated from measures of saliva flow rate (SFR) and absolute SIgA and salivary protein concentrations samples were collected before and after exercise testing. Peak and mean mechanical power output and exercise recovery heart rate were also measured. Of the 38 subjects initially enrolled in this investigation, 11 failed to complete one or more basic study requirements and the final data analyses were performed on measurements obtained from 27 subjects. Compared with rest, SSIgA, SIgA:protein ratio, and SFR were significantly lower after exercise at baseline.
Likewise, both peak and mean mechanical power output significantly declined across consecutive Wingate tests. Post intervention minus pre-intervention changes in scores for salivary parameters, exercise performance, and exercise heart rate recovery were similar between the treatment groups. These findings do not support the hypothesis that ginseng may affect mucosal immunity as indicated by changes in secretory IgA at rest and following an exercise-induced state of homeostatic disturbance. Supplementation with ginseng failed to improve physical performance and heart rate recovery of individuals undergoing repeated bouts of exhaustive exercise.
Strength/Power Performance. In an investigation by Kang, Kim, Lee, and Byrne (2002) , designed to assess the anabolic effects of ginseng ingestion on growth hormone, testosterone, cortisol, and insulin-like growth factor-1 to acute resistance exercise, 8 male college students were randomly administered 20 g of Korean red ginseng root extract or water immediately following a standardized exercise bout. The exercise consisted of a 7-repetition maximum of the half squat, bench press, 2-leg curl, arm curl, 2-leg extension, abdominal crunch, leg press, and chest press. Venous blood samples were drawn prior to and immediately following exercise and at again at 15-, 30-, 60-, and 120-minutes following exercise. Human growth hormone, testosterone, cortisol, and insulin-like growth factor-1 levels were determined by radioimmunoassay. The responses of plasma hormones did not differ significantly following the treatments. These results do not support the use of ginseng to promote anabolic hormonal status following resistance exercise.
Aerobic Exercise Performance. To evaluate the effectiveness of 14 days of treatment with Eleutherococcus senticosus (ES) (900 mg/day) as an ergogenic nutritional supplement, Chase, Darby, Liang, and Morgan (2000) employed a double-blind, crossover study with 11 participants performing four running trials before and following treadmill running performed at 80% of VO 2 max until volitional exhaustion following ES and placebo treatments. There was no statistically significant difference between trials for any of the dependent variables including time to exhaustion. The investigators concluded that 14 days of supplementation with Eleutherococcus senticosus has no ergogenic effect on metabolism and performance.
To determine if Panax quinquefolium attenuates creatine kinase level induced by aerobic endurance exercise in humans, Hsu, Ho, Lin, Su, and Hsu (2005) divided 13 male college students into a ginseng or placebo group. In a double-blind study, subjects received supplementation (400 mg, 4 per day) for 4 weeks, followed by a 4-week washout period, before crossing over and receiving the alternate treatment for the next 4 weeks. Treadmill running at 80% of VO 2 max was performed following each treatment.
Plasma creatine kinase and lactate were measured prior to the exercise, at 15 and 30 minutes during exercise, immediately after exercise, and 20, 40, 60, and 120 minutes after exercise. In addition, time to exhaustion and oxygen pulse were also measured.
While ginseng supplementation for 4 weeks prior to exhaustive aerobic treadmill running was associated with reduced leakage of creatine kinase from skeletal sarcoplasm into the blood during exercise, it did not enhance performance.
It has been reported by Kim, Park, Chang, and Sung (2005) 
that administration of
Panax ginseng increases endurance time to exhaustion. In this study, 7 sedentary males performed incremental exercise to volitional exhaustion on a treadmill before and following 8 weeks of panax ginseng extract administration. Exercise duration until exhaustion was significantly increased by 1.5 minutes, leading the investigators to conclude that ginseng has ergogenic properties. There are a number of reasons why these findings and conclusions must be viewed with caution. First, a small sample size of seven males served as participants, and these individuals served as their own controls. Second, the control testing was carried out prior to the ginseng intervention, and it is possible that an order effect took place. That is, the conditions should have been rotated and randomly assigned to the participants (i.e., AB and BA). Third, the participants were recruited on the basis that they "…had not performed any systematic training," and this is problematic for two reasons. First, pre-test sensitization may have taken place and second, the results cannot be generalized to athletes. Fourth, there was no blinding, and therefore, the observed results may have been due to the Halo effect, Hawthorne effect, demand characteristics, or expectancy effects.
In a double-blind, placebo-controlled investigation to determine the effectiveness of a moderately high dose of Panax notoginseng (a species of the genus Panax) on aerobic capacity, endurance, and mean blood pressure in young adults, Liang, Podolka, and Chuang (2005) randomly assigned 29 untrained adults to an experimental group or placebo control group. For 30 days, subjects in the experimental group consumed 1,350 mg per day of Panax notoginseng, while subjects in the control group consumed a placebo. Endurance time to exhaustion during cycle exercise was significantly improved in the experimental group by more than 7 minutes and mean blood pressure and oxygen consumption decreased during endurance exercise. The significant improvement in endurance time demonstrated by this investigation compared with others is noteworthy for several reasons: a relatively high dose of assayed ginseng was used, duration of consumption was for 30 days, and the type of ginseng consumed was Panax notoginseng, as opposed to the more frequently used Panax ginseng. In addition, the experimental design was comparatively rigorous being double-blind with random assignment of a moderate number of subjects to either a treatment or a placebo group. The investigators report that subjects were randomly assigned to the placebo and ginseng treatments, but there was a substantial difference in maximal oxygen consumption at the outset of the study. The entire point of using randomization is to insure that experimental and placebo groups are equivalent from the outset of a study on all variables of relevance to the inquiry. The effect size for the difference in maximal oxygen uptake was large (.81), and this is problematic. In other words, the ginseng group, for some reason, was superior to the placebo group from the outset on an important dimension of physical fitness.
Anaerobic Exercise Performance. To investigate the effects of ginseng supplementation on supramaximal exercise performance and short-term recovery, Engels, Kolokouri, Cieslak, and Wirth (2001) used a double-blind protocol and randomly assigned 24 healthy, active women to either a ginseng or a placebo treatment. Each participant added a standardized extract (400 mg G115) of Panax ginseng C.A. Meyer or a placebo to their normal diet for 8 weeks. Prior to and following the treatment period, each subject performed an all-out-effort, 30-second leg cycle ergometry test followed by a controlled recovery. Nineteen subjects completed the study. Of the 5 subjects lost to follow-up, 3
were from the placebo group and 2 were from the ginseng group. Results revealed no significant differences between the ginseng and placebo treatment groups for peak anaerobic power output, mean anaerobic power output, rate of fatigue, and immediate post exercise recovery heart rates. Engels et al. (2001) concluded that prolonged supplementation with ginseng had no ergogenic benefits during and following brief, supramaximal exercise. Effect sizes for the ginseng treatment were small (peak anaerobic power, 0.00; mean anaerobic power, 0.06; rate of fatigue, 0.38).
To determine the effects of ginseng supplementation on lactate threshold and physical performance, Kulaputana, Thanakomsirichot, and Anomasiri (2007) randomly assigned 57 physically active young men to either a ginseng (n = 28) or a placebo group (n = 29). Participants in the ginseng group consumed 3 gm of ginseng orally each day for 8 weeks. Blood lactic acid levels and heart rate responses were measured during incremental cycle ergometer work before and after the 8 weeks of treatment. Selected markers for liver and renal function were also monitored. Lactate threshold, exercise heart rate, total exercise time, and peak power output did not differ between ginseng and placebo groups, demonstrating in a well-controlled study (randomized, double-blinded, placebo-controlled, treatment compliance monitoring) that ginseng supplementation did not exert an ergogenic effect on the physical performance of a relatively large group of physically active young men.
The reports described in this section are summarized in Table 1. In conclusion, additional, well-designed research is needed to determine whether supplementation with ginseng and related products can improve performance and alleviate stress and fatigue when functional abilities are diminished such as through repetitive bouts of strenuous physical work. Moreover, the potential use of ginseng and related products to enhance performance, recovery, and muscle growth from anaerobic exercise has not yet been adequately investigated.
Psychological, Behavioral, and Cognitive Effects
While the positive effects of ginseng and ginseng-related products on psychological function, moods, behavior, stress reduction, and chronic pain in humans have been reported in a few of the earlier studies in this area -perhaps resulting from several central and peripheral physiological effects including cardiovascular, neural, and hormonal (Bahrke & Morgan, 1994; Bahrke & Morgan, 2000) , a more recent research study has failed to demonstrate enhanced mood following ginseng administration in healthy young adults.
Using a double-blind, placebo-controlled, randomized clinical trial, Cardinal and Engels (2001) examined the psychological well-being in healthy, young adults. Ninetysix adults were randomly assigned to one of three experimental conditions: placebo, 200 mg ginseng (Panax ginseng C.A. Meyer concentrate G115 in capsular format), or 400 mg ginseng (Panax ginseng C.A. Meyer concentrate G115 in capsular format). Each participant was given a 60-day supply of their respective supplement along with written instructions about proper intake and storage of the capsules over the 8-week study period and, a post-intervention appointment was scheduled for each participant. Eighty-three (or 86.5%) of the original participants completed the study with the primary reason for attrition being noncompliance with the study protocol. Positive affect, negative affect, and overall mood measures were obtained pre-and post-intervention. Ginseng supplementation had no effect on positive affect, negative affect, or overall mood leading the researchers to conclude chronic ginseng supplementation at either the clinically recommended dose, or at twice that level, does not enhance mood in healthy young adults. However, it may be that ginseng has little or no effect when administered to healthy adults scoring in the normal range on mood states. The investigators did not examine the effects of ginseng in those study participants with elevated mood scores.
In sports where quick decision-making is required, it is not unusual for athletes to consume products thought to provide an advantage over the competition. However, while previous research suggests chronic administration of ginseng can improve cognitive performance in humans (Bahrke & Morgan, 1994; Bahrke & Morgan, 2000) , previous research has not examined the effects of a single dose of ginseng on cognitive performance in healthy adults or with athletes.
In an investigation to determine if the acute administration of ginseng (G115) had any consistent effect on mood and cognitive performance in humans, Kennedy, Scholey, and Wesnes (2001a) used a placebo-controlled, double-blind, balanced, cross-over design. Quality of memory, speed of memory, quality of attention, and speed of attention served as the cognitive measures. Twenty, healthy young adult volunteers received 200, 400, and 600 mg of G115, and a matching placebo, in counterbalanced order, with a 7-day washout period between treatments. Following a baseline cognitive assessment, further test sessions took place at 1, 2.5, 4, and 6 hours after the day's treatment.
Significant improvement was found for quality of memory and the associated factor known as "secondary memory" at all points following the administration of 400 mg of ginseng. Both the 200 and 600 mg doses were associated with a significant decrement of the speed of attention at later testing times only. Subjective ratings of alertness were also reduced six hours following the two lowest doses (200 mg and 400 mg). These results indicate modulation of mood and cognitive performance may occur following acute administration of ginseng, but there is not a linear dose-response effect. That is, a moderate dose of 400 mg seems to enhance performance, while low (200 mg) and high (600 mg) doses impair performance. It would be noteworthy, of course, if similar results were found in exercise and sport settings.
In a subsequent investigation, but with different dosages, Kennedy, Scholey, and Wesnes (2001b) examined the effects of a combination of standardized extracts of Ginkgo biloba (GK501) and Panax ginseng (G115) on mood and selected aspects of cognitive performance (Quality of Memory, Speed of Memory, Quality of Attention, and Speed of Attention). Using a placebo-controlled, double-blind, balanced, cross-over design, 20 healthy, young adult volunteers received 320, 640, and 960 mg of the extract combination and a matching placebo in a random order with a 7-day washout period between treatments. Following a baseline cognitive assessment, further testing took place at 1, 2.5, 4, and 6 hours after the day's treatment. There was a dose-response improvement in performance on the quality of memory factor at the highest dose (960 mg). Additional analysis indicated this effect was differentially targeted at the secondary memory rather than the working memory component. There was also a dose-response decrement in performance of the speed of attention factor for both the 320 and 640 mg doses. The results of this study suggest that ingestion of single doses of a Ginkgo biloba and Panax ginseng combination can affect the cognitive performance of healthy young volunteers in a dose-response manner in that low doses are associated with performance decrements while high doses enhance performance. The underlying mechanism(s) for these effects remain to be elucidated.
In a related investigation, Kennedy, Scholey, and Wesnes (2002) , and an identical placebo on auditoryevoked potential using contingent negative variation and resting power within the delta, theta, alpha, and beta wavebands were evaluated in 15 healthy volunteers. Each subject was assessed on three separate occasions, 4 hours after consuming the treatment of the day. Seven days elapsed between testing sessions. Results indicated that ginseng led to a significant shortening of the latency of the P300 component of the evoked potential. Both ginseng and Ginkgo biloba led to significant reductions in frontal "eyes closed" theta and beta activity, with additional reduction for ginseng in the alpha waveband. These findings demonstrate that Panax ginseng can directly modulate cerebroelectrical activity, and that these effects are more pronounced than those following Ginkgo biloba. This potential for ginseng to enhance cognitive performance and mood has been reviewed in greater detail by and Scholey and Kennedy (2002) . It should also be noted that EEG data cannot be used as evidence of activity in sub-cortical regions, and there is a need for neuroimaging research (e.g., MRI, PET, SPECT) designed to elucidate the impact of ginseng use on various brain regions.
In one of the few ginseng administration studies conducted with athletes, improved psychomotor performance at rest and during graded exercise following ginseng treatment (350 mg/day for 6 weeks) in young athletes has been demonstrated by Ziemba, Chmura, Kaciuba-Uscilko, Nazar, Wisnik, and Gawronski (1999) . In a double-blind study, 15 soccer players underwent either ginseng treatment or placebo treatment. Prior to and following treatment all subjects performed an incremental bicycle ergometer exercise with intensity increasing 50 W every 3 minutes until volitional exhaustion (time to exhaustion data not presented). Reaction time was measured before exercise and during the last 2 minutes of each exercise load. Although neither ginseng nor placebo influenced VO 2 max or lactate threshold, ginseng treatment was associated with shortened reaction times at rest and during exercise.
To elucidate the mechanism(s) for the gluco-regulatory properties and enhancement of cognitive performance following ginseng administration, in a doubleblind, balanced-crossover study, Reay, Kennedy, and Scholey (2006) used a "cognitive demand" test battery at baseline, 30 minutes following administration of either ginseng or a placebo, and another 30 minutes later after consuming a drink containing glucose or a placebo. Both ginseng and glucose were associated with enhanced cognitive performance. Ginseng was associated with a reduction in blood glucose levels 1 hour following consumption when ingested without glucose, confirming ginseng may lower blood glucose levels and enhance cognitive performance. Although the mechanism(s) responsible for ginseng's glycemic effect or its cognitive effects were not clarified by this investigation, possible mechanisms for lower blood glucose levels and improved cognitive performance could include the modulation of glucose disposal, glucose transport, or insulin secretion.
The reports described in this section are summarized in Table 2 .
In conclusion, while current research supports the general finding that supplementation with ginseng and related products may modulate mood, improve cognitive performance, and decrease reaction time, the ecological validity of applying such results, primarily obtained using non-athletes in laboratory settings, to athletes and athletic environments is questionable.
Quality, Purity, and Bioavailability
Variability in herbal products, including ginseng, is a major concern as most dietary supplements are not subject to the same regulations as pharmaceuticals, and these herbal products may lack purity or potency. Hence, research involving herbal products is associated with major "sourcing" problems, and it is imperative that investigators assay the content of products employed in experiments designed to quantify efficacy. In our view, it is noteworthy that nearly all of the investigations in the present review failed to include an assay of the actual content of the substances used in the experiment.
To determine the variability in a range of ginseng herbal products available in the U.S., Harkey, Henderson, Gershwin, Stern, and Hackman (2001) identified and measured the concentration of marker compounds by using high performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry. Twentyfive commercial ginseng preparations of Panax ginseng or Eleutherococcus senticosus were obtained from a local health food store and analyzed for seven ginsenosides and two eleutherosides. All plant species were correctly identified by botanical plant species, but concentrations of marker compounds differed significantly from labeled amounts. There was also significant product-to-product variability and concentrations of ginsenosides varied by 15-and 36-fold in capsules and liquids respectively, and concentrations of eleutherosides varied by 43-and 200-fold in capsules and liquids respectively. The results of this survey suggest standardization for quality assurance is important in the design and evaluation of ginseng studies.
In a study to determine whether the commercial formulations of several botanical dietary supplements, including ginseng, had consistent labeling and whether quantities of marker compounds agreed with the amounts on the label, Krochmal, Hardy, Bowerman, Lu, Wang, Elashoff, and Heber (2004) purchased six bottles each of two lots of supplements from nine manufacturers and analyzed the contents using established commercial methodologies at an independent laboratory. Product labels were found to vary in the information provided, such as serving recommendations and information about the herb itself (e.g., species, part of the plant, marker compound). With regard to marker compound content, little variability was observed between different lots of the same brand, while the content did vary widely between brands (e.g., total ginsenosides ranged from 5.3 to 18.2 mg per serving). Further, the amounts recommended for daily use also differed between brands, increasing the potential range of a consumer's daily dose.
Ginseng was among the most variable. This study emphasizes the importance of standardized manufacturing practices and reliable labeling information.
Using HPLC to evaluate the effects of different samples of Panax quinquefolius on specimens cultivated in Wisconsin and Illinois, Yuan, Wang, Wu, Attlele, Xie, and Gu (2001) found considerable variability in the brainstem activity of neonatal rats for the two samples. In a comparison of six ginsenosides from these two specimens, data revealed remarkable variability in the total concentration and in the percentages of individual ginsenosides. For example, of the two major ginsenosides, the Illinois-cultivated Panax quinquefolius had 30% less ginsenoside Rb1 and 25% more ginsenoside Re than did the Wisconsin-cultivated Panax quinquefolius.
As part of a program for assessment of the quality of herbal medicines, Khan, Allgood, Walker, Abourashed, Schenk, and Benson (2001) analyzed 21 over-the-counter Panax ginseng products in various dosage forms including 8 liquid samples and 13 solid samples. Chromium, mercury, and arsenic were undetectable above their limits of detection in both liquid and solid samples, but cadmium, lead, and nickel were present in the majority of samples. Chlorinated pesticide levels varied widely in these samples. The total concentration of pesticides was below 100 ppb in most samples, but the total concentration exceeded 100 ppb in five samples. In addition, the U.S. Food and Drug Administration recently issued a warning that certain ginseng products are considered adulterated because they contain unsafe chemical residues from the pesticides procymidone and quintozene (Anonymous, 2005) . In another investigation examining the concentrations of cadmium, lead, mercury, and metalloid arsenic in dietetic products, Dragun, Puntaric, Prpic-Majic, Bosnir, Gmajnic, and Klaric (2003) found the highest concentration of mercury in a ginseng-based sample. Raman, Patino, and Nair (2004) failed to find unacceptable concentrations of metals such as lead and mercury in eight botanical dietary supplements including ginseng. However, these supplements were also evaluated for microbial contamination and most samples analyzed showed the presence of bacteria or fungi or both. These results serve to identify the problem of environmental contamination of dietary supplements and emphasize the necessity for developing validated quantitative methods for the analysis of such contaminants in the various herbal products presently available.
The above results also emphasize that future investigations of the effectiveness of ginseng should rely on the use of standardized methods and preparations. In fact, Sievenpiper, Arnason, Vidgen, Leiter, and Vuksan (2004) , after conducting a systematic quantitative analysis of the literature and finding a high coefficient of variation in ginsenosides across species, assay technique, and ginsenoside type concluded "…that until these issues are resolved, the reproducibility of ginseng's composition, safety, and efficacy cannot be trusted."
In an attempt to authenticate the differences between various types of Panax ginseng and, to offer confidence to consumers, Hon, Chow, Zeng, and Leung (2003) developed a set of microsatellite markers with discrete genotypes for American ginseng 
Adverse Effects, Drug Interactions, and Safety
The adverse effects associated with ginseng consumption have been reported previously (Bahrke & Morgan, 1994; Bahrke & Morgan, 2000) . While ginseng is thought to be relatively safe, several recent reports on the adverse effects of ginseng have been published. A systematic attempt to document and evaluate all of the available data on the safety of Panax ginseng root extracts has been conducted by Coon and Ernst (2002) . Data from clinical trials suggest the incidence of adverse events with ginseng monopreparations is similar to that of placebo. The most commonly experienced adverse effects are headache, sleep disturbances, and gastrointestinal disorders. The possibility of more serious adverse effects is indicated in isolated case study reports and data from spontaneous reporting schemes, but causality is often difficult to determine from the evidence provided. Combination products containing ginseng as one of several constituents have been associated with serious adverse events and even fatalities. Although a large number of investigations examining the effects of ginseng have been published, many of these studies have involved small numbers of participants, including case study reports. Case study reports are limited in their representativeness.
They do not necessarily allow valid generalizations to the population from which they came, and they are vulnerable to subjective biases. Case study reports may be selected because of their dramatic rather than typical attributes, or because they neatly fit an observer's pre-conceptions. Case study reports should encourage additional investigation with a greater number of subjects. Results of case studies can be used as hypotheses to be tested using rigorous experimental designs incorporating appropriate control and placebo paradigms.
The efficacy and safety of ginseng have also been evaluated by Kitts and Hu (2000) leading them to conclude "while some epidemiological or clinical studies have reported indications of efficacy for specific health benefits or potential toxicity, there are an equal number of studies that provide contradictory evidence" and further "this situation has lead to questionable conclusions concerning specific health benefits or risks associated with ginseng." Ernst (2002) has also examined the risk-benefit profile of several commonly used herbal therapies including ginseng and concluded that "wellconducted clinical trials do not support the efficacy of ginseng to treat any condition" and further "none of these herbal medicines are free of adverse effects."
When reports of adverse effects from herbal preparations are carefully assessed, it is often found the effects are not due to the herb(s) listed on the label, but rather the effects are due to adulteration or contamination of the declared ingredients. A case of ginseng-induced mania in a healthy 26-year-old male with no history of psychiatric illness has been reported by Engelberg, McCutcheon, and Wiseman (2001) Photosensitivity reaction in a woman using an herbal supplement containing ginseng, goldenseal, and bee pollen has been described by Palanisamy, Halter, and Olson (2003) . This 32-year-old woman suffered a phototoxic reaction after taking a dietary supplement containing ginseng, goldenseal, bee pollen, and other ingredients. The condition slowly resolved following discontinuation of the supplement and treatment with subcutaneous and topical corticosteroids. Although the individual ingredients in the dietary supplement have not been associated with cases of photosensitivity it is possible that the combination of ingredients may have interacted to cause the toxic reaction.
Caution is urged in the use of combined herbs and supplements in new formulations that have not been evaluated in controlled trials.
A case of anaphylactic reaction due to ingestion of Asian ginseng syrup in a 20-year-old male has also been reported by Wiwanitkit and Taungjaruwinai (2004) . Since ginseng is a widely consumed herb, potential adverse effects -such as allergic reaction, need to be emphasized.
Ginseng and Eleutherococcus senticosis have also been reported to interact with certain oral health drugs such as aspirin and corticosteroids, suggesting use of these products may be associated with various adverse reactions that can influence oral health and treatment. According to Abebe (2003) , dentists and dental hygienists need to be aware of these interactions and offer appropriate oral health care to individuals using these substances.
A case of menstrual alterations related to ginseng consumption has been reported by Palop-Larrea, Gonzalvez-Perales, Catalan-Oliver, Belenguer-Varea, and Martinez-Mir (2000) . A 48-year-old woman, who had never experienced menstrual disorders in the past, was admitted following a 3-week history of metrorrhagia following self-medication with three daily capsules for 2 months of a ginseng compound. A companion advised her to take the ginseng to improve her work performance. The metrorrhagia disappeared 4 days after discontinuing ginseng administration. More recently, Kabalak, Soyal, Urfalioglu, Saracoglu, and Gogus (2004) have also reported menometrorrhagia and tachyarrhythmia following use of oral and topical ginseng for cosmetic reasons in a 39-year-old female patient. The patient was advised to stop using ginseng capsules and ginseng cosmetics and her menometrorrhagia did not recur during the following 6 months. Given the extensive literature documenting menstrual dysfunction among female endurance athletes, extra caution may be warranted when using various ginseng preparations. With the many adverse effects associated with the use of ginseng, all users would be wise to exhibit caution.
Conclusions
Ginseng is one of the most popular herbal supplements in the world. It is widely used by the general public to increase work capacity and output and by athletes to enhance performance. In the present review we have provided an update of empirical research published since our two earlier reviews by focusing primarily on the efficacy of ginseng with respect to physical and athletic performance. We have updated the physiological effects of ginseng and ginseng-related products on physical activity, stress, and fatigue in humans; the psychological, behavioral, and cognitive effects; the quality, purity, and bioavailability of ginseng products; and the adverse health effects, drug interactions, and safety of ginseng.
While the effects of ginseng on pulmonary function, exercise capacity, and chronic fatigue have been reported in several earlier studies, many of these investigations were conducted with patients suffering from compromised pulmonary function and low levels of exercise capacity. Also, older individuals, suffering from chronic fatigue, often turn to herbal products such as ginseng for help in combating fatigue, while athletes often use ginseng for prevention and treatment of overtraining. The studies reviewed here have also been conducted with patients and elderly individuals and these results, when obtained from ill and older adults, cannot be applied to healthy, young athletes.
Athletes are also known to use Panax ginseng or Eleutherococcus senticosus believing these herbs decrease the incidence of colds and infections and enhance recovery from intense training. However, while previous and recent investigations reveal that ginseng and ginseng-related products may reduce inflammation and produce anti-stress adaptogenic activity and excitability in mice and rats as well as enhance physical performance, these effects are rarely evident in humans studied in well-designed investigations. Several recent investigations also reveal that supplementation with ginseng does not improve physical performance and recovery of individuals undergoing exhaustive exercise.
The positive effects of ginseng and ginseng-related products on psychological function, moods, behavior, stress reduction, and chronic pain in animals have been reported in a few of the earlier studies in this area that we have reviewed. Findings from recent investigations using animals generally tend to support these earlier reports.
However, while a few investigations reviewed here have demonstrated decreased levels of stress, anxiety, and pain following administration of ginseng and ginseng-related products to animals, ginseng administration in humans has not been shown to enhance mood in healthy young adults.
In sports where quick decision-making is required, it is not unusual for athletes to consume products thought to provide an advantage over the competition. Previous research suggests chronic administration of ginseng can improve cognitive performance in animals and in humans. However, while current research supports this general finding, the ecological validity of applying such results, obtained in laboratory settings, to athletes and athletic environments is questionable.
Many studies examining the pharmacological effects of ginseng and related products on humans engaged in physical performance such as that pursued by athletes frequently have not employed sound scientific design and methodology. For example, small numbers of subjects completing studies may have been inadequate in providing the statistical power needed to detect significant changes. There has also been a noticeable lack of double-blind and placebo-controlled investigations. Many of the studies reporting a positive influence of ginseng were supported by the supplier of the ginseng used in the various studies, but this potential conflict of interest has not been clearly stated in the published research. This is especially problematic where blind paradigms have not been employed.
Variability in ginseng preparations is also a major concern as most dietary supplements are not subject to the same regulations as pharmaceuticals, and these herbal products may lack purity or potency. Hence, research involving herbal products, including ginseng, is associated with major "sourcing" problems, and it is imperative that investigators assay the content of products employed in experiments designed to quantify efficacy. It is noteworthy that only a few of the investigations in the present review included an assay of the actual content of the substances used in the experiment. And, there has been little or no effort to confirm whether or not subjects have taken the prescribed ginseng (i.e., compliance). This emphasizes the need for future investigations in this area to use standardized preparations and methods.
It is important to recognize that adverse effects associated with ginseng consumption have been reported. Ginseng is thought to be relatively safe, and the most commonly experienced adverse effects are headache, sleep disturbances, and gastrointestinal disorders. However, several recent reports on the adverse effects of ginseng indicate that more severe outcomes can occur. These include ginseng-induced mania, transient ischemic attack, photosensitivity reaction, anaphylactic reaction, and menstrual dysfunction.
In summary, we conclude that despite attempts in recent investigations to improve upon the scientific rigor used in examining the ergogenic properties of ginseng, many of the same methodological shortcomings observed in earlier studies persist. Compelling evidence in support of enhanced physical performance following ginseng administration in humans participating in well-designed investigations remains to be demonstrated. Table 2 . Psychological, behavioral, and cognitive effects.
